Howard Pringle Leicester Cancer Research Center University of Leicester Biography Publications Institution JoVE Articles Howard Pringle has not added a biography. If you are Howard Pringle and would like to personalize this page please email our Author Liaison for assistance. Publications Development of a Patient-derived Explant Model for Prediction of Drug Responses in Endometrial Cancer Gynecologic Oncology. Feb, 2021 | Pubmed ID: 33309417 Evaluating and Comparing Immunostaining and Computational Methods for Spatial Profiling of Drug Response in Patient-derived Explants Laboratory Investigation; a Journal of Technical Methods and Pathology. Dec, 2020 | Pubmed ID: 33318618 The Sensitivity and Specificity of Novel Primers for Detection of BRAFV600E Mutation Asian Pacific Journal of Cancer Prevention : APJCP. Nov, 2020 | Pubmed ID: 33247675 Exploration of Matrix Effects in Laser Ablation Inductively Coupled Plasma Mass Spectrometry Imaging of Cisplatin-Treated Tumors Analytical Chemistry. 07, 2020 | Pubmed ID: 32545955 Patient-derived Explants (PDEs) As a Powerful Preclinical Platform for Anti-cancer Drug and Biomarker Discovery British Journal of Cancer. 03, 2020 | Pubmed ID: 31894140 Circulating Tumor DNA in Patients with Colorectal Adenomas: Assessment of Detectability and Genetic Heterogeneity Cell Death & Disease. 08, 2018 | Pubmed ID: 30166531 Correction To: Association of Invasion-promoting Tenascin-C Additional Domains with Breast Cancers in Young Women Breast Cancer Research : BCR. 08, 2018 | Pubmed ID: 30068377 Profiling Tumour Heterogeneity Through Circulating Tumour DNA in Patients with Pancreatic Cancer Oncotarget. Oct, 2017 | Pubmed ID: 29152076 5-Hydroxymethylcytosine is an Independent Predictor of Survival in Malignant Melanoma Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. 01, 2017 | Pubmed ID: 27713424 MicroRNA-10b is a Prognostic Biomarker for Melanoma Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Feb, 2016 | Pubmed ID: 26743475 Novel Plasma MicroRNA Biomarkers for the Identification of Colitis-associated Carcinoma Lancet (London, England). Feb, 2015 | Pubmed ID: 26312900 Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-positive Metastatic Breast Cancer Clinical Chemistry. Jul, 2015 | Pubmed ID: 25979954 Plasticity of Melanoma and EMT-TF Reprogramming Oncotarget. Jan, 2014 | Pubmed ID: 24369126 Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids PloS One. 2013 | Pubmed ID: 24205045 Accurate Detection of Copy Number Changes in DNA Extracted from Formalin-fixed, Paraffin-embedded Melanoma Tissue Using Duplex Ratio Tests The Journal of Molecular Diagnostics : JMD. Sep, 2013 | Pubmed ID: 23810241 Prognostic Tissue Markers in Melanoma Histopathology. Apr, 2012 | Pubmed ID: 21880059 Expression of CTGF and Cyr61 in Colorectal Cancer Journal of Clinical Pathology. Jan, 2011 | Pubmed ID: 21081514 Expression of Tenascin-C and Its Isoforms in the Breast Cancer Metastasis Reviews. Dec, 2010 | Pubmed ID: 20814719 Association of Invasion-promoting Tenascin-C Additional Domains with Breast Cancers in Young Women Breast Cancer Research : BCR. 2010 | Pubmed ID: 20678196 腫瘍関連テネイシン-Cアイソフォームは、マトリックスメタロプロテアーゼに依存し、独立したメカニズムによって、乳癌細胞の浸潤と成長を促進する Breast Cancer Research : BCR. 2009 | Pubmed ID: 19405959 WNT5A Expression Increases During Melanoma Progression and Correlates with Outcome Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2008 | Pubmed ID: 18794093 Characterization of E-cadherin-dependent and -independent Events in a New Model of C-Fos-mediated Epithelial-mesenchymal Transition Experimental Cell Research. Jan, 2007 | Pubmed ID: 17141758 Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation Frequencies Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2006 | Pubmed ID: 16899595 High BRAF Mutation Frequency Does Not Characterize All Melanocytic Tumor Types International Journal of Cancer. Sep, 2004 | Pubmed ID: 15252839 Inhibition of Endometrial Carcinoma Cell Growth Using Antisense Estrogen Receptor Oligodeoxyribonucleotides Anticancer Research. Nov-Dec, 2002 | Pubmed ID: 12553024 Mechanisms of Resistance to TRAIL-induced Apoptosis in Primary B Cell Chronic Lymphocytic Leukaemia Oncogene. Oct, 2002 | Pubmed ID: 12360407 Changes in Tenascin-C Isoform Expression in Invasive and Preinvasive Breast Disease Cancer Research. Jun, 2002 | Pubmed ID: 12036947 患者の薬剤耐性を予測するための「生きた」前臨床プラットフォームとしての患者由来腫瘍エクスプラント Giuditta Viticchié1, Ian Powley1, Constantinos Demetriou1, James Cooper1, Michael Butterworth1, Meeta Patel1, Naila Abid1, Gareth Miles1, Lynne Howells1, Howard Pringle1, Marion MacFarlane2, Catrin Pritchard1 1Leicester Cancer Research Center, University of Leicester, 2MRC Toxicology Unit JoVE 62130 Pesquisa do câncer
患者の薬剤耐性を予測するための「生きた」前臨床プラットフォームとしての患者由来腫瘍エクスプラント Giuditta Viticchié1, Ian Powley1, Constantinos Demetriou1, James Cooper1, Michael Butterworth1, Meeta Patel1, Naila Abid1, Gareth Miles1, Lynne Howells1, Howard Pringle1, Marion MacFarlane2, Catrin Pritchard1 1Leicester Cancer Research Center, University of Leicester, 2MRC Toxicology Unit JoVE 62130 Pesquisa do câncer